CLINICAL_TRIALS
trial_result
· 2017-10-09
Clinical Trial Update: Study Evaluating The Effects Of Neratinib After Adjuvant Trastuzumab In Women With Early Stage Breast Cancer [Phase 3]
Summary
Phase 3 trial evaluating neratinib after adjuvant trastuzumab in women with early-stage breast cancer has completed with results posted in 2017.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Puma Biotechnology, Inc. | Conditions: Breast Cancer | Phase 3 | Status: COMPLETED | Results posted: 2017-10-09